Naperville, IL -- (SBWIRE) -- 06/16/2014 -- Reportstack, provider of premium market research reports announces the addition of Belarus Pharmaceuticals and Healthcare Report Q3 2014 market report to its offering
The Belarusian economy is set to suffer a prolonged period of economic instability as a result of
a decline in global potash prices and an escalating trade war with Russia. If Russo-Belarusian relations
cannot be patched up, state revenues are set to decline considerably, the net exports deficit will widen
significantly and real GDP growth will decline. There are downside risks to our 2014 forecast, owing to the
threat of further currency depreciation, a collapse in exports and absolute erosion of consumer purchasing
power. With the balance of the Belarusian economy once more on knife's edge, Belarus will present little
reward for high risk for most pharmaceutical companies in the region.
Headline Expenditure Projections
Pharmaceuticals: BYR8,927bn in 2013 (USD1.00bn) to BYR11,039bn (USD1.05mn) in 2014; +23.7% in
local currency terms and +4.9% in US dollar terms.
Healthcare: BYR28,966bn (USD3.24bn) in 2013 to BYR35,066bn (USD3.34bn) in 2014; +21.4% in local
currency terms and +2.9% in US dollar terms.
To view the table of contents for this market research report please visit